Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Spira, Alexander I
234  Ergebnisse:
Personensuche X
?
1

A shared neoantigen vaccine combined with immune checkpoint..:

Rappaport, Amy R. ; Kyi, Chrisann ; Lane, Monica...
Nature Medicine.  30 (2024)  4 - p. 1013-1022 , 2024
Link: https://doi.org/10.1038/..
 
?
2

PP01.80 A retrospective observational study to evaluate pat..:

Biber, Josh ; Wan, Yin ; Churchill, Eric N....
Journal of Thoracic Oncology.  19 (2024)  7 - p. e36 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Impact of gender and mutational differences in hormone rece..:

Hsu, Robert ; Chen, Denaly ; Xia, Bing...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Pati..:

He, Kai ; Berz, David ; Gadgeel, Shirish M....
Journal of Thoracic Oncology.  18 (2023)  7 - p. 907-921 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-..:

Cascone, Tina ; Kar, Gozde ; Spicer, Jonathan D....
Cancer Discovery.  13 (2023)  11 - p. 2394-2411 , 2023
Link: https://doi.org/10.1158/..
 
?
6

Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mu..:

Cho, Byoung Chul ; Kim, Dong-Wan ; Spira, Alexander I....
Nature Medicine.  29 (2023)  10 - p. 2577-2585 , 2023
Link: https://doi.org/10.1038/..
 
?
7

Brief Report: Safety and Antitumor Activity of Durvalumab P..:

Garon, Edward B. ; Spira, Alexander I. ; Goldberg, Sarah B....
Journal of Thoracic Oncology.  18 (2023)  8 - p. 1094-1102 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and Safety of Brigatinib Compared With Crizotinib ..:

Ahn, Myung J. ; Kim, Hye R. ; Yang, James C.H....
Clinical Lung Cancer.  23 (2022)  8 - p. 720-730 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Individualized, heterologous chimpanzee adenovirus and self..:

Palmer, Christine D. ; Rappaport, Amy R. ; Davis, Matthew J....
Nature Medicine.  28 (2022)  8 - p. 1619-1629 , 2022
Link: https://doi.org/10.1038/..
 
?
10

A phase 1b study evaluating the safety and preliminary effi..:

Plummer, Ruth ; Dean, Emma ; Arkenau, Hendrik-Tobias...
Lung Cancer.  163 (2022)  - p. 19-26 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Characterization and management of adverse events observed ..:

Yang, James Chih-Hsin ; Zhou, Caicun ; Jänne, Pasi A....
Expert Review of Anticancer Therapy.  23 (2022)  1 - p. 95-106 , 2022
Link: https://doi.org/10.1080/..
 
?
12

The Effects of HER2 Alterations in EGFR Mutant Non-small Ce..:

Nagasaka, Misako ; Singh, Vijendra ; Baca, Yasmine...
Clinical Lung Cancer.  23 (2022)  1 - p. 52-59 , 2022
Link: https://doi.org/10.1016/..
 
?
13

A retrospective observational study of the natural history ..:

Spira, Alexander I. ; Tu, Huakang ; Aggarwal, Shivani...
Lung Cancer.  159 (2021)  - p. 1-9 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advance..:

Camidge, D. Ross ; Kim, Hye Ryun ; Ahn, Myung-Ju...
Journal of Thoracic Oncology.  16 (2021)  12 - p. 2091-2108 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Characterization of KRAS Mutation Subtypes in Non–small Cel..:

Judd, Julia ; Abdel Karim, Nagla ; Khan, Hina...
Molecular Cancer Therapeutics.  20 (2021)  12 - p. 2577-2584 , 2021
Link: https://doi.org/10.1158/..
 
1-15